In endometrial cancer cell lines, the phosphorylation of several downstream targets such as AKT and PDK1 in the PI3K pathway is markedly upregulated, which supports the view that ARID1A is a new regulator in the PI3K pathway (40). The gene discussed is ARID1A; the disease is endometrial cancer.